RATIONALE: Shellfish allergy is one of the most common food allergies self-reported in adults. It is estimated to be 60% of seafood allergy in the United States. However, prevalence of physician diagnosed shellfish allergy is unknown. The aim was to characterize the prevalence of shellfish allergy in our population. METHODS: We used clinical looking glass database to retrospectively identify patients who were seen in the primary care setting (Internal Medicine (IM), Family Medicine (FM) clinics) and allergy clinics at Montefiore Medical Center from 2014-2016 with a diagnosis for shellfish allergy. Crab, lobster and shrimp IgE levels were collected, when performed. RESULTS: Of 199,203 patients seen in Internal medicine (IM) and family medicine (FM) clinics, 2,255 (1.13%) had documented shellfish allergy. Of these, 324 (14%) were seen in allergy clinic. An additional 4,133 patients were not seen in IM or FM clinics but had documented shellfish allergy. Total population of individuals with documented shellfish allergy was 6,388. Of these 6,388 individuals, the number of individuals that were seen in allergy clinic was 529 (8.3%). Only 88 (1.4%) had IgE levels for crustacean shellfish checked. Of these, 45 (51.1%) IgE level was <0.35 kU/L. CONCLUSIONS: Based on our data, even though large portion of the population carries a documentation of shellfish allergy, only a small portion had serum specific IgE to crustacean shellfish checked. Half had negative results. This suggests that we may be over estimating true shellfish allergy. Further prospective studies need to be done to identify those who have true IgE mediated shellfish allergy. Landspitali the National Universtiy Hospital, Reykjavik, Iceland. RATIONALE: The timing of the introduction of egg to infant's diet is of current interest. Therefore, meta-analysis of the existing literature was conducted to evaluate whether the early introduction of egg to infants influences the development of egg allergy and whether dosage or nature of the allergen and atopy status can influence the results. METHODS: Literature searches were conducted in MEDLINE, EMBASE and CENTRAL, and trial protocols were searched in Meta Register and OpenGREY. Only randomized controlled trials (RCTs) comparing early (between 3-6 months of age) egg introduction to no early introduction were included. The primary outcome was the development of egg allergy. RESULTS: Of the 416 articles identified and screened, 6 RCTs met the eligibility criteria for data extraction. Allergic outcomes were evaluated in a total of 3032 participants. A moderate level of evidence showed a benefit of the early introduction of egg (relative risk [RR], 0.60; 95% CI, 0.44-0.82; P 5 .002; mild heterogeneity [I 2 5 23%]). There were variable doses of egg protein exposure, with a median dose of 2800 mg/week (range 350 -7500 mg/week). Consumption of <4000 mg/week of egg protein had a greater preventive effect than a higher dose. CONCLUSIONS: This systematic review and meta-analysis showed an association between the early introduction of egg and a possible lower risk of egg allergy. Furthermore, the nature and dose of egg protein exposure may play a role. These findings should be addressed in the context of the primary studies.
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A Comparison Of Food Allergic Patients With And Without Atopic Dermatitis
Bryce C. Hoffman, MD, Marco A. Ramirez-Gama, BS, Douglas C. Everett, PhD, Shannon L. Garcia, BS, Elena Goleva, PhD, Donald Y. M. Leung, MD, PhD, FAAAAI, and Christine B. Cho, MD; National Jewish Health, Denver, CO. RATIONALE: Food allergy (FA) in atopic dermatitis (AD) occurs because food allergens penetrate a dysfunctional skin barrier to induce sensitization. It is unknown whether FA patients without AD have a defective skin barrier, and in what capacity the skin may affect FA. This study compared clinical characteristics and skin barrier function of FA patients with and without AD. METHODS: 469 food allergic patients from age 0-18 years were included in this study and divided into groups with or without a history of AD. FA was defined based on a history of an immediate clinical reaction with a positive skin prick test or specific IgE level. 6 non-AD peanut allergic patients and 6 non-atopic controls had skin barrier assessment with transepidermal water loss (TEWL) measurements and skin tape stripping. RESULTS: AD with FA had a significantly higher occurrence of egginduced anaphylaxis than FA without AD (p50.003). In contrast, AD with FA and AD without FA had a similar prevalence of peanut-induced anaphylaxis. Food-specific IgE levels were similar between groups. More AD patients had allergic rhinitis compared to non-AD (p<0.001) but similar proportions had asthma. 3 of 6 non-AD peanut allergic patients had TEWL area-under-the-curve measurements >550 g/m 2 /h over 20 tape strips compared to 0 of 6 controls. High TEWL patients had increased peanut-specific IgE and anaphylaxis rate. CONCLUSIONS: AD has an increased association with egg-induced, but not peanut-induced, anaphylaxis. Allergic rhinitis is more common in AD, suggesting a propensity to the atopic march. Surprisingly, skin barrier abnormalities exist in 50% of FA patients without AD.
